Effect of intravenous immunoglobulin therapy on the prognosis of patients with severe fever with thrombocytopenia syndrome and neurological complications
ConclusionProlonged high-dose IVIG is beneficial to the 28-day prognosis in SFTS patients with neurological complications.
Source: Frontiers in Immunology - Category: Allergy & Immunology Source Type: research
More News: Allergy & Immunology | Brain | Headache | Laboratory Medicine | Migraine | Neurology | Statistics | Study | Thrombocytopenia